Bibliographic Details
| Title: |
How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management? |
| Authors: |
Hadley, Trevor D., Agha, Ali M., Ballantyne, Christie M. |
| Source: |
Current Atherosclerosis Reports; Jun2021, Vol. 23 Issue 6, p1-7, 7p |
| Abstract: |
Purpose of Review: The potential of polygenic risk scores (PRS) to improve atherosclerotic cardiovascular disease (ASCVD) risk assessment and management has stoked significant interest in their incorporation into clinical management. The goal of this review is to apprise the readers of the latest developments and evidence of PRS readiness for clinical integration. We also discuss current limitations that must be addressed before PRS can be implemented into routine clinical practice. Recent Findings: PRS have been shown to improve risk stratification for ASCVD and to identify patients who may derive increased benefit from primary and secondary prevention. Risk captured by PRS appears largely independent of traditional risk factors and can be ascertained at birth, prior to the development of traditional clinical risk factors. Genetic risk is modifiable through lifestyle modifications and medications. Summary: PRS offers a valuable way to improve early identification of actionable CVD risk. However, further work is needed before PRS can be implemented clinically. [ABSTRACT FROM AUTHOR] |
|
Copyright of Current Atherosclerosis Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
